Mpox Declines in Ghana: A Public Health Success That Must Be Sustained

Ghana’s response to Mpox has reached an encouraging turning point. The Minister of Health has announced that the disease is no longer classified as a Public Health Emergency of International Concern, reflecting a steady decline in infections and the impact of coordinated public health action.

Recent data show that weekly Mpox infections have fallen sharply from 28 cases to just seven. At present, only one patient remains hospitalized with the virus and there are no critical cases. The downward trend signals that Ghana’s public health interventions, particularly vaccination campaigns and widespread public sensitization, are yielding results.

Since the outbreak began in May 2025, the country has recorded 1,038 confirmed Mpox cases across 124 districts, with eight deaths reported. The Greater Accra and Western regions have been the most affected areas, reflecting both population density and patterns of movement that increase exposure risk.

Vaccination has played a key role in containing the spread. So far, 31,231 people have received Mpox vaccines in the Ashanti, Western, and Greater Accra regions. These efforts, combined with sustained public education campaigns, have helped communities better understand how the disease spreads and how it can be prevented.

The government’s decision to cover medical bills for Mpox patients has also been a critical component of the national response. By removing financial barriers to treatment, authorities have encouraged early reporting and care-seeking, which helps prevent further transmission. Alongside this support, health authorities continue to implement home isolation protocols for mild cases and expand laboratory testing capacity to ensure timely diagnosis.

Mpox, formerly known as monkeypox, is not a new disease. It was first identified in monkeys in 1958, with the first human case recorded in 1970 in the Democratic Republic of Congo. The virus typically causes symptoms such as fever, rash, headaches, muscle aches, back pain, and swollen lymph nodes. While most infections are mild, severe cases can occur, particularly among vulnerable populations.

Treatment for Mpox is largely supportive, though antiviral medications may be used in severe cases. Prevention remains the most effective strategy. Vaccination, avoiding contact with infected individuals or contaminated materials, and maintaining good hygiene practices such as regular handwashing and disinfecting surfaces are essential measures that help reduce transmission.

Ghana’s progress in controlling Mpox demonstrates what is possible when government institutions, health professionals, and communities work together. Public education has strengthened awareness, while vaccination and early treatment have reduced the severity and spread of the disease.

Yet this progress should not lead to complacency. Infectious disease outbreaks can resurface quickly if vigilance declines. Continued surveillance, sustained vaccination efforts, and ongoing public education remain essential to ensure that Mpox does not regain a foothold.

The lessons from this outbreak extend beyond Mpox itself. They highlight the importance of resilient health systems, transparent communication, and strong community engagement in managing public health threats. Ghana’s experience shows that timely action, backed by public trust and institutional coordination, can turn the tide against emerging diseases.